High-intensity focused ultrasound ablation as an adjuvant surgical salvage procedure in gestational trophoblastic neoplasia chemotherapy with chemoresistance or recurrence: two case reports

References

• Abu-Rustum NR, Yashar CM, Bean S, et al. Gestational trophoblastic neoplasia, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(11):1374–1391.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Zhou Q, Wu XH, et al. Guidelines for the diagnosis and treatment of gestational trophoblastic diseases. Chin J Pract Gynecol Obstet. 2018;34(9):994–1001.
   Google Scholar
• Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5(4):321–327.
   PubMed Web of Science ®Google Scholar
• Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93(8):890–895.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem. 2004;11(3–4):149–154.
   PubMed Web of Science ®Google Scholar
• Lin Z, Gong C, Huang Q, et al. A comparison of results following the treatment of placenta accreta and placenta increta using high-intensity focused ultrasound followed by hysteroscopic resection. Int J Hyperthermia. 2021;38(1):576–581.
   PubMed Web of Science ®Google Scholar
• Zhu X, Deng X, Wan Y, et al. High-intensity focused ultrasound combined with suction curettage for the treatment of cesarean scar pregnancy. Medicine. 2015;94(18):e854.
   PubMed Web of Science ®Google Scholar
• Ngan HYS, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynecol Obstet. 2018;143:79–85.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhao W, Zhang YQ, et al. Curative effects and influenced factors of EMA-CO as an initial regimen for the treatment of high-risk gestational trophoblastic neoplasia. Zhonghua yi Xue za Zhi. 2018;98(47):3896–3899.
   PubMedGoogle Scholar
• Lurain JR, Nejad B. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2005;97(2):618–623.
   PubMed Web of Science ®Google Scholar
• Newlands ES. The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN). Best Pract Res Clin Obstet Gynaecol. 2003;17(6):905–923.
   PubMed Web of Science ®Google Scholar
• Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2011;204(1):11–18.
   PubMed Web of Science ®Google Scholar
• Feng FZ, Xiang Y, Cao Y, et al. Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm. Zhonghua Fu Chan Ke Za Zhi. 2008;43(10):728–731.
   PubMedGoogle Scholar
• Lurain JR, Singh DK, Schink JC. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med. 2006;51(10):773–776.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Bae SN, Kim JH, et al. Effects of multiagent chemotherapy and independent risk factors in the treatment of high‐risk GTT-25 years experiences of KRI‐TRD. Int J Gynecol Obstet. 1998;60:S85–S96.
   Web of Science ®Google Scholar
• Eysbouts YK, Massuger LFAG, IntHout J, et al. The added value of hysterectomy in the management of gestational trophoblastic neoplasia. Gynecol Oncol. 2017;145(3):536–542.
   PubMed Web of Science ®Google Scholar
• Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376(9742):717–729.
   PubMed Web of Science ®Google Scholar
• Wang ZB, Wu F, Wang ZL, et al. Targeted damage effects of high intensity focused ultrasound (HIFU) on liver tissues of Guizhou province miniswine. Ultrason Sonochem. 1997;4(2):181–182.
   PubMed Web of Science ®Google Scholar
• Kong Y, Zong L, Cheng H, et al. Management and risk factors of recurrent gestational trophoblastic neoplasia: an update from 2004 to 2017. Cancer Med. 2020;9(7):2590–2599.
   PubMed Web of Science ®Google Scholar
• Balachandran K, Salawu A, Ghorani E, et al. When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): a national analysis on over 4,000 patients. Gynecol Oncol. 2019;155(1):8–12.
   PubMed Web of Science ®Google Scholar
• McNeish IA, Strickland S, Holden L, et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol. 2002;20(7):1838–1844.
   PubMed Web of Science ®Google Scholar
• Alazzam M, Tidy J, Osborne R, et al. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2012;12:CD008891.
   PubMed Web of Science ®Google Scholar
• Peng M, Ding Y, Yu L, et al. Tegafur substitution for 5-Fu in combination with actinomycin D to treat gestational trophoblastic neoplasm. PLoS One. 2015;10(11):e0143531.
   PubMed Web of Science ®Google Scholar
• McGrath S, Short D, Harvey R, et al. The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU L(-1). Br J Cancer. 2010;102(5):810–814.
   PubMed Web of Science ®Google Scholar
• Cao Y, Xiang Y, Feng F, et al. Surgical resection in the management of pulmonary metastatic disease of gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2009;19(4):798–801.
   PubMed Web of Science ®Google Scholar
• Orsi F, Zhang L, Arnone P, et al. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR Am J Roentgenol. 2010;195(3):W245–W252.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Cao YD, et al. Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation. Ann Surg Oncol. 2007;14(3):1237–1242.
   PubMed Web of Science ®Google Scholar
• Lu P, Zhu XQ, Xu ZL, et al. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer. Surgery. 2009;145(3):286–293.
   PubMed Web of Science ®Google Scholar
• Eranki A, Srinivasan P, Ries M, et al. High-intensity focused ultrasound (HIFU) triggers immune sensitization of refractory murine neuroblastoma to checkpoint inhibitor therapy. Clin Cancer Res. 2020;26(5):1152–1161.
   PubMed Web of Science ®Google Scholar